CARD14 mutations may predict response to antitumour necrosis factor‐α therapy in psoriasis: a potential further step towards personalized medicine

por Wu, K.C.P., Reynolds, N.J.
Publicado 2016

Methotrexate Toxicity During Treatment of Chronic Plaque Psoriasis: A Case Report and Review of the Literature

por Weidmann, Anja, Foulkes, Amy C., Kirkham, N., Reynolds, N. J.
Publicado 2014

Translating translation into patient benefit for atopic eczema

por Reynolds, N.J., Sinha, A., Elias, M.S., Meggitt, S.J.
Publicado 2016

NFAT signalling is a novel target of oncogenic BRAF in metastatic melanoma

por Flockhart, R J, Armstrong, J L, Reynolds, N J, Lovat, P E
Publicado 2009

Treatment of moderate‐to‐severe atopic eczema in adults within the U.K.: results of a national survey of dermatologists

por Taylor, K., Swan, D.J., Affleck, A., Flohr, C., Reynolds, N.J.
Publicado 2017

NFAT regulates induction of COX-2 and apoptosis of keratinocytes in response to ultraviolet radiation exposure

por Flockhart, R. J., Diffey, B. L., Farr, P. M., Lloyd, J., Reynolds, N. J.
Publicado 2008

Priority research questions in atopic dermatitis: an International Eczema Council eDelphi consensus

por Abuabara, K., Nicholls, S.G., Langan, S.M., Guttman‐Yassky, E., Reynolds, N.J., Paller, A.S., Brown, S.J.
Publicado 2021

Comparative effectiveness of biological therapies on improvements in quality of life in patients with psoriasis

por Iskandar, I.Y.K., Ashcroft, D.M., Warren, R.B., Lunt, M., McElhone, K., Smith, C.H., Reynolds, N.J., Griffiths, C.E.M.
Publicado 2017

Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study

por Warren, R.B., Marsden, A., Tomenson, B., Mason, K.J., Soliman, M.M., Burden, A.D., Reynolds, N.J., Stocken, D., Emsley, R., Griffiths, C.E.M., Smith, C.
Publicado 2018

Community Priority setting for Fetal Alcohol Spectrum Disorder Research in Australia

por Finlay-Jones, A, Symons, M, Tsang, W, Mullan, R, Jones, H, McKenzie, A, Reibel, Cannon, L, Birda, B, Reynolds, N, Sargent, P, Gailes, H, Mayers, D, Elliott, EJ, Bower, C
Publicado 2020

Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermato...

por Yiu, Z.Z.N., Ashcroft, D.M., Evans, I., McElhone, K., Lunt, M., Smith, C.H., Walton, S., Murphy, R., Reynolds, N.J., Ormerod, A.D., Griffiths, C.E.M., Warren, R.B.
Publicado 2018

Psoriasis treat to target: defining outcomes in psoriasis using data from a real‐world, population‐based cohort study (the British Association of Dermatologists Biologics and Immun...

por Mahil, S.K., Wilson, N., Dand, N., Reynolds, N.J., Griffiths, C.E.M., Emsley, R., Marsden, A., Evans, I., Warren, R.B., Stocken, D., Barker, J.N., Burden, A.D., Smith, C.H.
Publicado 2019

Persistence and effectiveness of nonbiologic systemic therapies for moderate‐to‐severe psoriasis in adults: a systematic review

por Mason, K.J., Williams, S., Yiu, Z.Z.N., McElhone, K., Ashcroft, D.M., Kleyn, C.E., Jabbar‐Lopez, Z.K., Owen, C.M., Reynolds, N.J., Smith, C.H., Wilson, N., Warren, R.B., Griffiths, C.E.M.
Publicado 2019

Epidermal autophagy and beclin 1 regulator 1 and loricrin: a paradigm shift in the prognostication and stratification of the American Joint Committee on Cancer stage I melanomas

por Ellis, R., Tang, D., Nasr, B., Greenwood, A., McConnell, A., Anagnostou, M.E., Elias, M., Verykiou, S., Bajwa, D., Ewen, T., Reynolds, N.J., Barrett, P., Carling, E., Watson, G., Armstrong, J., Allen, A.J., Horswell, S., Labus, M., Lovat, P.E.
Publicado 2019

What is the evidence for interactions between filaggrin null mutations and environmental exposures in the aetiology of atopic dermatitis? A systematic review

por Blakeway, H., Van‐de-Velde, V., Allen, V.B., Kravvas, G., Palla, L., Page, M.J., Flohr, C., Weller, R.B., Irvine, A.D., McPherson, T., Roberts, A., Williams, H.C., Reynolds, N., Brown, S.J., Paternoster, L., Langan, S.M.
Publicado 2020

Live-cell three-dimensional single-molecule tracking reveals modulation of enhancer dynamics by NuRD

por Basu, S., Shukron, O., Hall, D., Parutto, P., Ponjavic, A., Shah, D., Boucher, W., Lando, D., Zhang, W., Reynolds, N., Sober, L. H., Jartseva, A., Ragheb, R., Ma, X., Cramard, J., Floyd, R., Balmer, J., Drury, T. A., Carr, A. R., Needham, L.-M., Aubert, A., Communie, G., Gor, K., Steindel, M., Morey, L., Blanco, E., Bartke, T., Di Croce, L., Berger, I., Schaffitzel, C., Lee, S. F., Stevens, T. J., Klenerman, D., Hendrich, B. D., Holcman, D., Laue, E. D.
Publicado 2023

Anakinra for palmoplantar pustulosis: results from a randomized, double‐blind, multicentre, two‐staged, adaptive placebo‐controlled trial (APRICOT)

por Cro, S., Cornelius, V.R., Pink, A.E., Wilson, R., Pushpa‐Rajah, A., Patel, P., Abdul‐Wahab, A., August, S., Azad, J., Becher, G., Chapman, A., Dunnill, G., Ferguson, A.D., Fogo, A., Ghaffar, S.A., Ingram, J.R., Kavakleiva, S., Ladoyanni, E., Leman, J.A., Macbeth, A.E., Makrygeorgou, A., Parslew, R., Ryan, A.J., Sharma, A., Shipman, A.R., Sinclair, C., Wachsmuth, R., Woolf, R.T., Wright, A., McAteer, H., Barker, J.N.W.N., Burden, A.D., Griffiths, C.E.M., Reynolds, N.J., Warren, R.B., Lachmann, H.J., Capon, F., Smith, C.H.
Publicado 2021